UMIN-CTR History

UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials


Unique ID issued by UMIN UMIN000004647
Receipt No. R000005539
Scientific Title Phase II clinical trial of third-line Panitumumab and irinotecan or Panitumumab therapy for patients with KRAS wild-type unresectable/recurrent colorectal cancer
Date of disclosure of the study information 2010/12/01
Last modified on 2012/05/08 16:19:40

No. Disposal Last modified on Item of update
1 Insert 2010/12/01 16:53:14
2 Update 2011/06/01 11:24:55 Institutions
3 Update 2011/06/01 11:35:01 Key secondary outcomes
4 Update 2012/05/08 16:18:22 Email
Post marketing survey by drug manufacture etc., specified by Japanese law.
5 Update 2012/05/08 16:19:40 Recruitment status

Contact us.